Display options
Share it on

Cytotechnology. 1996 Jan;22(1):197-203. doi: 10.1007/BF00353939.

Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ.

Cytotechnology

L Monaco, A Marc, A Eon-Duval, G Acerbis, G Distefano, D Lamotte, J M Engasser, M Soria, N Jenkins

Affiliations

  1. Department of Biological & Technological Research, San Raffaele Scientific Institute, Milan, Italy.

PMID: 22358930 DOI: 10.1007/BF00353939

Abstract

The CHO cell line has achieved considerable commercial importance as a vehicle for the production of human therapeutic proteins, but is known to lack a functional copy of the gene coding for α2,6-sialyltransferase (EC 2.4.99.1). The cDNA for rat α2,6-ST was expressed in a recombinant CHO cell line making interferon-γ, using a novel in vitro amplification vector. The enzyme was expressed efficiently, and resulted in up to 60% of the total sialic acids on interferon-γ being linked in the α2,6-conformation. This sialic acid linkage distribution was more akin to that seen in natural human glycoproteins. In the most successful cell clones, expression of α2,6-sialyltransferase improved the overall level of sialylation by up to 56%, and had no adverse effects on cell growth, IFN-γ productivity or other aspects of IFN-γ glycosylation. These experiments demonstrate how the glycosylation machinery of rodent cells can be genetically manipulated to replicate human tissues.

References

  1. Biotechnol Prog. 1995 May-Jun;11(3):348-51 - PubMed
  2. Biotechnology (N Y). 1990 May;8(5):421-7 - PubMed
  3. Biotechnol Appl Biochem. 1994 Oct;20(2):157-71 - PubMed
  4. J Biol Chem. 1987 Dec 25;262(36):17735-43 - PubMed
  5. Biochem Soc Trans. 1995 Feb;23(1):1-25 - PubMed
  6. Biotechnology (N Y). 1991 Dec;9(12):1347-55 - PubMed
  7. Appl Microbiol Biotechnol. 1991 Feb;34(5):559-64 - PubMed
  8. Biotechnology (N Y). 1995 Jun;13(6):592-6 - PubMed
  9. Methods Enzymol. 1994;230:168-99 - PubMed
  10. Annu Rev Immunol. 1993;11:571-611 - PubMed
  11. Appl Microbiol Biotechnol. 1992 Oct;38(1):84-90 - PubMed
  12. Glycobiology. 1991 Sep;1(4):337-46 - PubMed
  13. Biotechnol Appl Biochem. 1995 Feb;21(1):87-100 - PubMed
  14. Cytotechnology. 1994;15(1-3):209-15 - PubMed
  15. Anal Biochem. 1994 Nov 1;222(2):315-22 - PubMed
  16. Biochim Biophys Acta. 1995 May 11;1244(1):223-8 - PubMed
  17. Biotechnology (N Y). 1995 Jul;13(7):692-8 - PubMed
  18. Anal Biochem. 1992 Nov 1;206(2):430-6 - PubMed
  19. J Biochem. 1995 Jan;117(1):59-62 - PubMed
  20. Enzyme Microb Technol. 1994 May;16(5):354-64 - PubMed
  21. Eur J Biochem. 1995 Sep 15;232(3):718-25 - PubMed
  22. J Biol Chem. 1989 Aug 15;264(23):13848-55 - PubMed
  23. Nat Biotechnol. 1996 Aug;14(8):975-81 - PubMed
  24. Biotechnol Bioeng. 1995 Dec 20;48(6):639-48 - PubMed
  25. Biotechnol Bioeng. 1995 Jun 5;46(5):399-407 - PubMed
  26. Biotechnology (N Y). 1991 Jan;9(1):64-8 - PubMed
  27. Biochem J. 1995 Apr 1;307 ( Pt 1):47-55 - PubMed
  28. J Biol Chem. 1990 Jul 25;265(21):12127-30 - PubMed
  29. Biotechnology (N Y). 1993 Aug;11(8):887-93 - PubMed
  30. Trends Biochem Sci. 1991 Oct;16(10):374-7 - PubMed

Publication Types